These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Lake JR; Hammond MV; Shaddox RC; Hunsicker LM; Yang HY; Malin DH Neurosci Lett; 1991 Oct; 132(1):29-32. PubMed ID: 1787914 [TBL] [Abstract][Full Text] [Related]
3. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944 [TBL] [Abstract][Full Text] [Related]
4. Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions. Malin DH; Henceroth MM; Izygon JJ; Nghiem DM; Moon WD; Anderson AP; Madison CA; Goyarzu P; Ma JN; Burstein ES Neurosci Lett; 2015 Jan; 584():141-5. PubMed ID: 25459291 [TBL] [Abstract][Full Text] [Related]
5. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice. Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Malin DH; Lake JR; Arcangeli KR; Deshotel KD; Hausam DD; Witherspoon WE; Carter VA; Yang HY; Pal B; Burgess K Life Sci; 1993; 53(17):PL261-6. PubMed ID: 8412495 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome. Malin DH; Lake JR; Smith DA; Jones JA; Morel J; Claunch AE; Stevens PA; Payza K; Ho KK; Liu J Drug Alcohol Depend; 1995 Nov; 40(1):37-42. PubMed ID: 8746922 [TBL] [Abstract][Full Text] [Related]
8. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Stinus L; Allard M; Gold L; Simonnet G Peptides; 1995; 16(7):1235-41. PubMed ID: 8545244 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Kavaliers M; Innes D Peptides; 1992; 13(3):603-7. PubMed ID: 1523172 [TBL] [Abstract][Full Text] [Related]
10. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice. Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF. Malin DH; Lake JR; Jones JA; Morel J; Moon WD; Corbit BP; Smith DA; Claunch AE; Kacher D; Stevens PA; Webb SL Peptides; 1996; 17(4):615-8. PubMed ID: 8804070 [TBL] [Abstract][Full Text] [Related]
12. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats. Kotlinska J; Pachuta A; Dylag T; Silberring J Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254 [TBL] [Abstract][Full Text] [Related]
13. The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol. Kotlinska J; Pachuta A; Dylag T; Silberring J Neuropeptides; 2007 Feb; 41(1):51-8. PubMed ID: 17107711 [TBL] [Abstract][Full Text] [Related]
14. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. Malin DH; Lake JR; Short PE; Blossman JB; Lawless BA; Schopen CK; Sailer EE; Burgess K; Wilson OB Pharmacol Biochem Behav; 1996 Jul; 54(3):581-5. PubMed ID: 8743632 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide FF (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice. Kavaliers M; Colwell DD Neurosci Lett; 1993 Jul; 157(1):75-8. PubMed ID: 8233035 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance. Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017 [TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice. Gelot A; Francés B; Gicquel S; Zajac JM Eur J Pharmacol; 1998 Oct; 358(3):203-6. PubMed ID: 9822885 [TBL] [Abstract][Full Text] [Related]
18. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Quelven I; Roussin A; Burlet-Schiltz O; Gouardères C; Tafani JA; Mazarguil H; Zajac JM Eur J Pharmacol; 2002 Aug; 449(1-2):91-8. PubMed ID: 12163111 [TBL] [Abstract][Full Text] [Related]
19. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs. Gouardères C; Sutak M; Zajac JM; Jhamandas K Eur J Pharmacol; 2000 Oct; 406(3):391-401. PubMed ID: 11040346 [TBL] [Abstract][Full Text] [Related]
20. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Oberling P; Stinus L; Le Moal M; Simonnet G Peptides; 1993; 14(5):919-24. PubMed ID: 8284268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]